vimarsana.com
Home
Live Updates
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-N
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-N
177Lu-Dotatate Prolongs PFS vs High-Dose Octreotide in GEP-NETs
Lutetium Lu 177 dotatate plus octreotide significantly improved PFS vs high-dose octreotide in patients with gastroenteropancreatic neuroendocrine tumors.
Related Keywords
,
Advanced Accelerator ,
177lu Dotatate ,
Gep Nets ,
Nets ,
Gastroenteropancreatic Neuroendocrine Tumors ,
Neuroendocrine Tumors ,
Lutetium Lu 177 Dotatate ,
Somatostatin Analog ,
Lutathera ,
Phase 3 Netter 2 Trial ,
2024 Gastrointestinal Cancers Symposium ,
Asco Gi ,
Simron Singh ,
D ,
Bph ,
Sunnybrook Health Sciences Centre ,